title: [The cost of an HIV patient. Lack of funds for optimal treatment?].
abstract: Many patients with HIV--a group in urgent need of effective health care measures--are extremely worried by current discussions on budgeting, fearing, as daily practice shows, restrictions on vitally indicated services. The present article describes the results of a recent health economics study of the direct and indirect costs generated by HIV infection.
authors.affiliation: Zentrum Innere Medizin, Medizinischen Hochschule Hannover. stoll.matthias@mh-hannover.de
authors.forename: M
authors.initials: M
authors.lastname: Stoll
authors.forename: E
authors.initials: E
authors.lastname: Schulte
authors.forename: C
authors.initials: C
authors.lastname: Claes
authors.forename: J M
authors.initials: JM
authors.lastname: Graf von der Schulenburg
authors.forename: R E
authors.initials: RE
authors.lastname: Schmidt
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000191:economics*; D003363:Cost Control / Q000639:trends; D005544:Forecasting; D005858:Germany; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics*; D006301:Health Services Needs and Demand / Q000191:economics*; D006801:Humans; D009313:National Health Programs / Q000191:economics*; D011785:Quality Assurance, Health Care / Q000191:economics*
chemical_list: D019380:Anti-HIV Agents